Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 198

1.

Oxidative stress and increased formation of vasoconstricting F2-isoprostanes in patients with reversible cerebral vasoconstriction syndrome.

Chen SP, Chung YT, Liu TY, Wang YF, Fuh JL, Wang SJ.

Free Radic Biol Med. 2013 Aug;61:243-8. doi: 10.1016/j.freeradbiomed.2013.04.022. Epub 2013 Apr 19.

PMID:
23608464
2.

Influence of isoprostanes on vasoconstrictor effects of noradrenaline and angiotensin II.

Sametz W, Grobuschek T, Hammer-Kogler S, Juan H, Wintersteiger R.

Eur J Pharmacol. 1999 Jul 28;378(1):47-55.

PMID:
10478564
3.

Transcranial color doppler study for reversible cerebral vasoconstriction syndromes.

Chen SP, Fuh JL, Chang FC, Lirng JF, Shia BC, Wang SJ.

Ann Neurol. 2008 Jun;63(6):751-7. doi: 10.1002/ana.21384.

PMID:
18496847
4.

Identification of the major urinary metabolite of the F2-isoprostane 8-iso-prostaglandin F2alpha in humans.

Roberts LJ 2nd, Moore KP, Zackert WE, Oates JA, Morrow JD.

J Biol Chem. 1996 Aug 23;271(34):20617-20.

5.

Reversible cerebral vasoconstriction syndrome and migraine: sonography study.

Alpaidze M, Beridze M.

Georgian Med News. 2014 Mar;(228):28-36.

PMID:
24743119
6.

Specific and rapid quantification of 8-iso-prostaglandin F2alpha in urine of healthy humans and patients with Zellweger syndrome by gas chromatography-tandem mass spectrometry.

Tsikas D, Schwedhelm E, Fauler J, Gutzki FM, Mayatepek E, Frölich JC.

J Chromatogr B Biomed Sci Appl. 1998 Sep 25;716(1-2):7-17.

PMID:
9824213
7.

Reversible cerebral vasoconstriction syndrome: an under-recognized clinical emergency.

Chen SP, Fuh JL, Wang SJ.

Ther Adv Neurol Disord. 2010 May;3(3):161-71. doi: 10.1177/1756285610361795.

8.

Prostaglandin F(2alpha) metabolite and F(2)-isoprostane excretion rates in migraine.

Helmersson J, Mattsson P, Basu S.

Clin Sci (Lond). 2002 Jan;102(1):39-43.

PMID:
11749659
9.

Cerebral endothelial dysfunction in reversible cerebral vasoconstriction syndrome: a case-control study.

Choi HA, Lee MJ, Chung CS.

J Headache Pain. 2017 Dec;18(1):29. doi: 10.1186/s10194-017-0738-x. Epub 2017 Feb 23.

10.

Reversible cerebral vasoconstriction syndrome after blood transfusion.

Dou YH, Fuh JL, Chen SP, Wang SJ.

Headache. 2014 Apr;54(4):736-44. doi: 10.1111/head.12319. Epub 2014 Mar 13.

PMID:
24628283
11.

Reduced circulating endothelial progenitor cells in reversible cerebral vasoconstriction syndrome.

Chen SP, Wang YF, Huang PH, Chi CW, Fuh JL, Wang SJ.

J Headache Pain. 2014 Dec 2;15:82. doi: 10.1186/1129-2377-15-82.

12.

Brain-derived neurotrophic factor gene Val66Met polymorphism modulates reversible cerebral vasoconstriction syndromes.

Chen SP, Fuh JL, Wang SJ, Tsai SJ, Hong CJ, Yang AC.

PLoS One. 2011 Mar 18;6(3):e18024. doi: 10.1371/journal.pone.0018024.

13.

A common cause of sudden and thunderclap headaches: reversible cerebral vasoconstriction syndrome.

Cheng YC, Kuo KH, Lai TH.

J Headache Pain. 2014 Mar 1;15:13. doi: 10.1186/1129-2377-15-13.

14.

Tandem mass spectrometric quantification of 8-iso-prostaglandin F2alpha and its metabolite 2,3-dinor-5,6-dihydro-8-iso-prostaglandin F2alpha in human urine.

Schwedhelm E, Tsikas D, Durand T, Gutzki FM, Guy A, Rossi JC, Frölich JC.

J Chromatogr B Biomed Sci Appl. 2000 Jul 7;744(1):99-112.

PMID:
10985571
15.

Quantification of 8-iso-prostaglandin-F(2alpha) and 2,3-dinor-8-iso-prostaglandin-F(2alpha) in human urine using liquid chromatography-tandem mass spectrometry.

Liang Y, Wei P, Duke RW, Reaven PD, Harman SM, Cutler RG, Heward CB.

Free Radic Biol Med. 2003 Feb 15;34(4):409-18.

PMID:
12566066
16.

Transcranial Doppler Ultrasonography As a Non-Invasive Tool for Diagnosis and Monitoring of Reversible Cerebral Vasoconstriction Syndrome.

Levin JH, Benavides J, Caddick C, Laurie K, Wilterdink J, Yaghi S, Silver B, Khan M.

R I Med J (2013). 2016 Sep 1;99(9):38-41.

PMID:
27579950
17.

8-iso-prostaglandin F2alpha as a useful clinical biomarker of oxidative stress in ESRD patients.

Lim PS, Chang YM, Thien LM, Wang NP, Yang CC, Chen TT, Hsu WM.

Blood Purif. 2002;20(6):537-42.

PMID:
12566669
18.
19.

Urinary 8-iso-prostaglandin F2alpha as a risk marker in patients with coronary heart disease: a matched case-control study.

Schwedhelm E, Bartling A, Lenzen H, Tsikas D, Maas R, Brümmer J, Gutzki FM, Berger J, Frölich JC, Böger RH.

Circulation. 2004 Feb 24;109(7):843-8. Epub 2004 Feb 2.

20.

Increased urinary excretion of 8-iso-prostaglandin F2alpha in patients with HFE-related hemochromatosis: a case-control study.

Kom GD, Schwedhelm E, Nielsen P, Böger RH.

Free Radic Biol Med. 2006 Apr 1;40(7):1194-200. Epub 2005 Dec 13.

PMID:
16545687

Supplemental Content

Support Center